| Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates P Maisonnasse, J Guedj, V Contreras, S Behillil, C Solas, R Marlin, ... Nature 585 (7826), 584-587, 2020 | 396 | 2020 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ... Cell 184 (5), 1188-1200. e19, 2021 | 170 | 2021 |
| Arsenic exposure and intestinal microbiota in children from Sirajdikhan, Bangladesh X Dong, N Shulzhenko, J Lemaitre, RL Greer, K Peremyslova, ... PLoS One 12 (12), e0188487, 2017 | 64 | 2017 |
| An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates N Zabaleta, W Dai, U Bhatt, C Hérate, P Maisonnasse, JA Chichester, ... Cell host & microbe 29 (9), 1437-1453. e8, 2021 | 63 | 2021 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ... Nature communications 12 (1), 6097, 2021 | 48 | 2021 |
| SARS-CoV-2 viral dynamics in non-human primates A Gonçalves, P Maisonnasse, F Donati, M Albert, S Behillil, V Contreras, ... PLoS computational biology 17 (3), e1008785, 2021 | 44 | 2021 |
| Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques R Marlin, V Godot, S Cardinaud, M Galhaut, S Coleon, S Zurawski, ... Nature communications 12 (1), 5215, 2021 | 30 | 2021 |
| Non-human primate models of human respiratory infections J Lemaitre, T Naninck, B Delache, J Creppy, P Huber, M Holzapfel, ... Molecular immunology 135, 147-164, 2021 | 28 | 2021 |
| Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates R Marlin, D Desjardins, V Contreras, G Lingas, C Solas, P Roques, ... Nature Communications 13 (1), 5108, 2022 | 23 | 2022 |
| Mass cytometry reveals the immaturity of circulating neutrophils during SIV infection J Lemaitre, A Cosma, D Desjardins, O Lambotte, R Le Grand Journal of innate immunity 12 (2), 170-181, 2020 | 17 | 2020 |
| Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivax P Christensen, A Racklyeft, KE Ward, J Matheson, R Suwanarusk, ... Parasitology International 89, 102589, 2022 | 13 | 2022 |
| Local innate markers and vaginal microbiota composition are influenced by hormonal cycle phases C Adapen, L Réot, N Nunez, C Cannou, R Marlin, J Lemaître, R Le Grand, ... Frontiers in immunology 13, 841723, 2022 | 13 | 2022 |
| Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection G Sulbaran, P Maisonnasse, A Amen, G Effantin, D Guilligay, ... Cell Reports Medicine 3 (2), 2022 | 12 | 2022 |
| Expansion of immature neutrophils during SIV infection is associated with their capacity to modulate T-cell function J Lemaitre, D Desjardins, AS Gallouët, M Gomez-Pacheco, C Bourgeois, ... Frontiers in Immunology 13, 781356, 2022 | 12 | 2022 |
| Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells C Passaes, D Desjardins, A Chapel, V Monceaux, J Lemaitre, A Mélard, ... Nature Communications 15 (1), 178, 2024 | 11 | 2024 |
| Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques N Zabaleta, U Bhatt, C Hérate, P Maisonnasse, J Sanmiguel, C Diop, ... Molecular Therapy 30 (9), 2952-2967, 2022 | 9 | 2022 |
| Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque A Olivo, R Marlin, T Lazure, P Maisonnasse, L Bossevot, C Mouanga, ... Communications Biology 5 (1), 542, 2022 | 9 | 2022 |
| SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19 S Temmam, X Montagutelli, C Herate, F Donati, B Regnault, M Attia, ... EMBO reports 24 (4), e56055, 2023 | 7 | 2023 |
| Viral dynamic modeling of SARS-CoV-2 in non-human primates A Gonçalves, P Maisonnasse, F Donati, M Albert, S Behillil, V Contreras, ... | 6 | 2020 |
| Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates T Naninck, N Kahlaoui, J Lemaitre, P Maisonnasse, A De Mori, Q Pascal, ... Iscience 25 (4), 2022 | 5 | 2022 |
